APTK Stock Overview
Public Joint-Stock Company Pharmacy Chain 36.6 operates pharmacies in Russia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Public Joint-Stock Company Pharmacy Chain 36.6 Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₽12.50 |
| 52 Week High | ₽15.30 |
| 52 Week Low | ₽8.39 |
| Beta | 0.34 |
| 1 Month Change | 0% |
| 3 Month Change | -0.032% |
| 1 Year Change | -8.90% |
| 3 Year Change | 4.13% |
| 5 Year Change | 39.62% |
| Change since IPO | -93.46% |
Recent News & Updates
Shareholder Returns
| APTK | RU Consumer Retailing | RU Market | |
|---|---|---|---|
| 7D | 0% | 0.2% | 0.7% |
| 1Y | -8.9% | -1.6% | 2.8% |
Return vs Industry: APTK underperformed the Russian Consumer Retailing industry which returned 9.7% over the past year.
Return vs Market: APTK exceeded the Russian Market which returned -38.2% over the past year.
Price Volatility
| APTK volatility | |
|---|---|
| APTK Average Weekly Movement | n/a |
| Consumer Retailing Industry Average Movement | 4.0% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in RU Market | 9.8% |
| 10% least volatile stocks in RU Market | 2.4% |
Stable Share Price: APTK has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine APTK's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | n/a | Alexander Kuzin | pharmacychain366.ru |
Public Joint-Stock Company Pharmacy Chain 36.6 operates pharmacies in Russia. Its pharmacies offer health and beauty products. The company serves customers under the 36.6, Romir, and Gorzdrav brands.
Public Joint-Stock Company Pharmacy Chain 36.6 Fundamentals Summary
| APTK fundamental statistics | |
|---|---|
| Market cap | ₽95.35b |
| Earnings (TTM) | -₽165.00m |
| Revenue (TTM) | ₽41.06b |
2.3x
P/S Ratio-578.0x
P/E RatioIs APTK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| APTK income statement (TTM) | |
|---|---|
| Revenue | ₽41.06b |
| Cost of Revenue | ₽26.71b |
| Gross Profit | ₽14.35b |
| Other Expenses | ₽14.51b |
| Earnings | -₽165.00m |
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.022 |
| Gross Margin | 34.94% |
| Net Profit Margin | -0.40% |
| Debt/Equity Ratio | -308.7% |
How did APTK perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/10/05 14:45 |
| End of Day Share Price | 2022/07/08 00:00 |
| Earnings | 2021/06/30 |
| Annual Earnings | 2020/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Public Joint-Stock Company Pharmacy Chain 36.6 is covered by 7 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ivan Nikolaev | Aton LLC |
| Vladislav Metnev | BCS Global Markets |
| Elena Jouronova | J.P. Morgan |